Overview

A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)

Status:
Withdrawn
Trial end date:
2021-11-04
Target enrollment:
Participant gender:
Summary
Randomized, double-blind, active-controlled, parallel-group study of HTD1801 in adolescents.
Phase:
Phase 2
Details
Lead Sponsor:
HighTide Biopharma Pty Ltd
Treatments:
Ursodeoxycholic Acid